Qian Pei, Bao Ying, Huang Hui-Mei, Suo Lei, Han Yan, Li Zhi-Juan, Zhang Min
Department of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Front Pediatr. 2023 Jan 13;10:1009188. doi: 10.3389/fped.2022.1009188. eCollection 2022.
X-linked Alport syndrome (XLAS) is caused by pathogenic variants in and is characterized by progressive kidney disease, hearing loss, and ocular abnormalities.The aim of this study was to identify gene mutations in a Chinese family with XLAS, confirm a diagnosis, and provide an accurate genetic counseling.
The proband was a 5-year-old male with microscopic hematuria and a family history of renal disease in 5 relatives.His relatives had microhematuria with or without proteinuria. His maternal uncle developed renal failure at the age of 35 years. He was evaluated by renal biopsy,whole-exome sequencing (WES) and whole-genome sequencing (WGS) for Alport syndrome. RT-PCR and cDNA Sanger sequencing were performed on RNA extracted from the skin of the proband. Then, a splicing reporter minigene assay was used to examine the effect of the variation on the splicing of the primary transcript in transfected cells.
Pathological examination of the kidney of the proband revealed diffuse thinning of the glomerular basement membrane, and immunofluorescence analysis indicated normal expression of the 5 chain in the basement membrane. No phenotype-associated candidate variant was detected in the proband WES. A novel deep intronic variant (c.385-716G > A), which is segregated with disease in this family, was identified using WGS. In-vitro minigene assay and in-vivo RT-PCR analysis demonstrated that the variant could produce both normal and abnormal transcripts. The abnormal transcripts showed that the variant activated a cryptic splice site, introducing a 147 bp pseudoexon into the mRNA sequence and consequently generating a premature termination codon (.G129Afs*38) and leading to frameshifting and truncation of the 5 (collagen IV) protein.
This is the first report of the novel c.385-716G > A splicing mutation in the COL4A5 gene, which illustrates the importance of performing WGS to find additional mutations in WES-negative patients with highly suspected forms of genetic diseases. The same results obtained from the in-vitro and in-vivo splicing experiments confirm the consistency between the minigene assay and RT-PCR analysis. In addition, this study highlights the importance of functional analysis in diagnosis and genetic counseling in AS.
X连锁遗传性肾炎(XLAS)由[基因名称]的致病变异引起,其特征为进行性肾病、听力丧失和眼部异常。本研究旨在鉴定一个中国XLAS家系中的基因突变,确诊疾病,并提供准确的遗传咨询。
先证者为一名5岁男性,有镜下血尿,其5名亲属有肾病家族史。他的亲属有镜下血尿,伴或不伴蛋白尿。他的舅舅在35岁时发展为肾衰竭。对他进行了肾活检、全外显子组测序(WES)和全基因组测序(WGS)以诊断遗传性肾炎。对从先证者皮肤提取的RNA进行了RT-PCR和cDNA Sanger测序。然后,使用剪接报告基因小基因分析来检测该变异对转染细胞中初级转录本剪接的影响。
先证者肾脏的病理检查显示肾小球基底膜弥漫性变薄,免疫荧光分析表明基底膜中α5链表达正常。在先证者的WES中未检测到与表型相关的候选变异。使用WGS鉴定出一个新的内含子深处变异(c.385-716G>A),该变异在这个家系中与疾病共分离。体外小基因分析和体内RT-PCR分析表明,该变异可产生正常和异常转录本。异常转录本显示该变异激活了一个隐蔽剪接位点,在mRNA序列中引入了一个147 bp的假外显子,从而产生一个提前终止密码子(p.G129Afs*38),导致α5(IV型胶原)蛋白移码和截断。
这是首次报道COL4A5基因新的c.385-716G>A剪接突变,这说明了对高度怀疑患有遗传性疾病且WES结果为阴性的患者进行WGS以发现其他突变的重要性。体外和体内剪接实验获得的相同结果证实了小基因分析和RT-PCR分析之间的一致性。此外,本研究强调了功能分析在遗传性肾炎诊断和遗传咨询中的重要性。